Evidence map›Paper›PMID 27067893›Full record

ReviewBMJ open2016

Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.

Anja Maria Brænd, Jørund Straand, Rune Bruhn Jakobsen, Atle Klovning

Abstract readReview
In one paragraph

Review in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Time to publication for results of clinical trials.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Article
  3. Clinical trial publications.Saudi journal of anaesthesia · 2019
    Review
  4. Scientific Misconduct: A Global Concern.Journal of obstetrics and gynaecology of India · 2018
    Article
  5. Review
  6. Review
  7. Review
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anja Maria BrændFaculty of Medicine, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Jørund StraandFaculty of Medicine, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Rune Bruhn JakobsenFaculty of Medicine, Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway Department of Orthopedic Surgery, Akershus University Hospital, Lørenskog, Norway.
Atle KlovningFaculty of Medicine, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPreviously, we identified a 10-year cohort of protocols from applications to the Norwegian Medicines Agency 1998-2007, consisting of 196 drug trials in general practice. The aim of this study was to examine whether trial results were published and whether trial funding and conflicts of interest were reported.

designCohort study of trials with systematic searches for published results.

settingClinical drug trials in Norwegian general practice.

methodsWe performed systematic literature searches of MEDLINE, Embase and CENTRAL to identify publications originating from each trial using characteristics such as test drug, comparator and patient groups as search terms. When no publication was identified, we contacted trial sponsors for information regarding trial completion and reference to any publications.

main outcome measuresWe determined the frequency of publication of trial results and trial characteristics associated with publication of results.

resultsOf the 196 trials, 5 were never started. Of the remaining 191 trials, 71% had results published in a journal, 11% had results publicly available elsewhere and 18% of trials had no results available. Publication was more common among trials with an active comparator drug (χ(2) test, p=0.040), with a larger number of patients (total sample size≥median, p=0.010) and with a longer trial period (duration≥median, p=0.025). Trial funding was reported in 85% of publications and increased over time, as did reporting of conflicts of interest among authors. Among the 134 main journal articles from the trials, 60% presented statistically significant results for the investigational drug, and the conclusion of the article was favourable towards the test drug in 78% of papers.

conclusionsWe did not identify any journal publication of results for 29% of the general practice drug trials. Trials with an active comparator, larger and longer trials were more likely to be published.

Indexed as

Clinical Trials as TopicDrug EvaluationGeneral PracticePublishingResearch ReportCohort StudiesEditorial PoliciesHumansNorwayPublication BiasPublicationsRegistriesResearch Support as TopicDrug industryGeneral practiceMedical writingPRIMARY CAREPublication bias

Identifiers

PMID27067893
PMCPMC4838717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.